Target intelligence / Profile preview

SRY-box transcription factor 12 (SOX12)

Target
SOX12
Molecular classification
Transcription factor, DNA-binding protein, High mobility group (HMG) domain protein, SOX family (specifically SOXC subgroup)
01

Overview

SRY-box transcription factor 12 (SOX12) is a protein-coding gene belonging to the SOX (SRY-related HMG-box) family of transcription factors, specifically to the SOXC subgroup which also includes SOX4 and SOX11[1][2][4]. Members of the SOX family are characterized by the presence of a DNA-binding high mobility group (HMG) domain, which enables them to regulate gene expression by binding DNA and influencing chromatin structure. SOX12 functions primarily as a transcriptional activator, sometimes in cooperation with other transcription factors such as POU3F2/BRN2 or POU3F1/OCT6[1]. It participates in tissue differentiation, maintenance of cell types, organ development, and immune function through T cell differentiation[1][2]. Disruption or mutations in SOX12 are associated with certain developmental disorders, but, unlike some other SOX proteins, SOX12 knockout mice do not display strong phenotypes, likely due to redundancy with SOX4 and SOX11[2]. There is no current evidence supporting direct druggability or active therapeutic targeting of SOX12, although other SOX proteins are being investigated for roles in cancer[3][4].

Other names
SOX12SOX22SRY-box 12
02

Biological functions

Regulation of gene transcriptionCell fate determinationCell differentiationTissue maintenanceOrganogenesisT-cell differentiation (especially regulatory T cell differentiation under inflammatory conditions)
03

Disease associations

Intellectual developmental disorder with speech delay and dysmorphic faciesAcromesomelic dysplasia 2APotential, but not definitively established, roles in cancer (mainly described for other SOX family members)

Beyond the preview

Go deeper on SRY-box transcription factor 12 (SOX12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SRY-box transcription factor 12 (SOX12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call